THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
functional cDNA cloning of a seven-transmembrane, G protein-
coupled receptor. Science 1996; 272: 872-877.
recombination and co-receptor utilization. Virology 2001;
283;19-30.
79. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a
RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor
for macrophage-tropic HIV-1. Science 1996; 272: 1955-1958.
80. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors
for HIV-1 infection of microglia. Nature 1997; 385: 645-649.
81. Watkins BA, Dorn HH, Kelly WB, et al. Specific tropism of HIV-
1 for microglial cells in primary human brain cultures. Science
1990; 249: 549-553.
100. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency
virus type 1 subtypes differ in disease progression. J Infect Dis
1999; 179: 68-73.
101. Drosopoulos WC, Rezende LF, Wainberg MA, et al. Virtues of
being faithful: can we limit the genetic variation in human
immunodeficiency virus? J Mol Med 1998; 76: 604-612.
102. Kimata JT, Kuller L, Anderson DB, et al. Emerging cytopathic and
antigenic simian immunodeficiency virus variants influence
AIDS progression. Nat Med 1999; 5: 535-541.
82. Power C, McArthur JC, Johnson RT, et al. Distinct HIV-1 env
sequences are associated with neurotropism and neurovirulence.
Curr Top Microbiol Immunol 1995; 202: 89-104.
103. Hughes ES, Bell JE, Simmonds P. Investigation of the dynamics of
the spread of human immunodeficiency virus to brain and other
tissues by evolutionary analysis of sequences from the p17gag
and env genes. J Virol 1997; 71: 1272-1280.
83. Jordan CA, Watkins BA, Kufta C, et al. Infection of brain
microglial cells by human immunodeficiency virus type 1 is
CD4 dependent. J Virol 1991; 65: 736-742.
104. Power C, Buist R, Johnston JB, et al. Neurovirulence in feline
immunodeficiency virus-infected neonatal cats is viral strain
specific and dependent on systemic immune suppression. J Virol
1998; 72: 9109-9115.
84. Chan SY, Speck RF, Power C, et al. V3 recombinants indicate a
central role for CCR5 as a coreceptor in tissue infection by
human immunodeficiency virus type 1. J Virol 1999; 73: 2350-
2358.
105. Phillips TR, Prospero-Garcia O, Puaoi DL, et al. Neurological
abnormalities associated with feline immunodeficiency virus
infection. J Gen Virol 1994; 75: 979-987.
85. Strizki JM, Albright AV, Sheng H, et al. Infection of primary human
microglia and monocyte-derived macrophages with human
immunodeficiency virus type 1 isolates: evidence of differential
tropism. J Virol 1996; 70: 7654-7662.
106. Mankowski JL, Flaherty MT, Spelman JP, et al. Pathogenesis of
simian immunodeficiency virus encephalitis: viral determinants
of neurovirulence. J Virol 1997; 71: 6055-6060.
86. Chesebro B, Wehrly K, Nishio J, et al. Macrophage-tropic human
immunodeficiency virus isolates from different patients exhibit
unusual V3 envelope sequence homogeneity in comparison with
T-cell-tropic isolates: definition of critical amino acids involved
in cell tropism. J Virol 1992; 66: 6547-6554.
107. Mankowski JL, Spelman JP, Ressetar HG, et al. Neurovirulent
simian immunodeficiency virus replicates productively in
endothelial cells of the central nervous system in vivo and in
vitro. J Virol 1994; 68: 8202-8208.
87. Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120
envelope glycoprotein in complex with the CD4 receptor and a
neutralizing human antibody. Nature 1998; 393: 648-659.
88. Sanders VJ, Pittman CA, White MG, et al. Chemokines and
receptors in HIV encephalitis. AIDS 1998; 12: 1021-1026.
89. Zheng J, Ghorpade A, Niemann D, et al. Lymphotropic virions
affect chemokine receptor-mediated neural signaling and
apoptosis: implications for human immunodeficiency virus type
1-associated dementia. J Virol 1999; 73: 8256-8267.
108. Johnston JB, Jiang Y, van Marle G, et al. Lentiviral infection in the
brain induce matrix metalloproteinase expression: the role of
envelope diversity. J Virol 2000; 74: 7211-7220.
109. Power C, McArthur JC, Nath A, et al. Neuronal death induced by
brain-derived human immunodeficiency virus type 1 envelope
genes differs between demented and nondemented AIDS
patients. J Virol 1998; 72: 9045-9053.
110. Smit TK, Wang B, Ng T, et al. Varied tropism of HIV-1 isolates
derived from different regions of adult brain cortex discriminate
between patients with and without AIDS dementia complex
(ADC): evidence for neurotropic HIV variants. Virology 2001;
279: 509-526.
90. Kaul M, Lipton SA. Chemokines and activated macrophages in
HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S
A 1999; 96: 8212-8216.
91. Harouse JM, Bhat S, Spitalnik SL, et al. Inhibition of entry of HIV-
1 in neural cell lines by antibodies against galactosyl ceramide.
Science 1991; 253: 320-323.
111. Smith K, Crandall KA, Kneissl ML, et al. PCR detection of host
and HIV-1 sequences from archival brain tissue. J Neurovirology
2000; 6: 164-171.
92. Ma M, Geiger JD, Nath A. Characterization of a novel binding site
for the human immunodeficiency virus type 1 envelope protein
gp120 on human fetal astrocytes. J Virol 1994; 68: 6824-6828.
93. Chesebro B, Nishio J, Perryman S, et al. Identification of human
immunodeficiency virus envelope gene sequences influencing
viral entry into CD4-positive HeLa cells, T-leukemia cells, and
macrophages. J Virol 1991; 65: 5782-5789.
112. Ohagen A, Ghosh S, He J, et al. Apoptosis induced by infection of
primary brain cultures with diverse human immunodeficiency
virus type 1 isolates: evidence for a role of the envelope. J Virol
1999; 73: 897-906.
113. Nath A, Geiger J. Neurobiological aspects of human
immunodeficiency virus infection: neurotoxic mechanisms. Prog
Neurobiol 1998; 54: 19-33.
94. Westervelt P, Trowbridge DB, Epstein LG, et al. Macrophage
tropism determinants of human immunodeficiency virus type 1
in vivo. J Virol 1992; 66: 2577-2582.
114. Dreyer EB, Kaiser PK, Offermann JT, et al. HIV-1 coat protein
neurotoxicity prevented by calcium channel antagonists. Science
1990; 248: 364-367.
95. Morris A, Marsden M, Halcrow K, et al. Mosaic structure of the
human immunodeficiency virus type 1 genome infecting
lymphoid cells and the brain: evidence for frequent in vivo
recombination events in the evolution of regional populations. J
Virol 1999; 73: 8720-8731.
115. Kaiser PK, Offermann JT, Lipton SA. Neuronal injury due to HIV-
1 envelope protein is blocked by anti-gp120 antibodies but not
by anti-CD4 antibodies. Neurology 1990; 40: 1757-1761.
116. Barks JD, Liu XH, Sun R, et al. gp120, a human immunodeficiency
virus-1 coat protein, augments excitotoxic hippocampal injury in
perinatal rats. Neuroscience 1997; 76: 397-409.
96. Mayne M, Bratanich AC, Chen P, et al. HIV-1 tat molecular
diversity and induction of TNF-alpha: implications for HIV-
induced neurological disease. Neuroimmunomodulation 1998; 5:
184-192.
117. Giulian D, Wendt E, Vaca K, et al. The envelope glycoprotein of
human immunodeficiency virus type 1 stimulates release of
neurotoxins from monocytes. Proc Natl Acad Sci U S A 1993;
90: 2769-2773.
97. Corboy JR, Buzy JM, Zink MC, et al. Expression directed from
HIV long terminal repeats in the central nervous system of
transgenic mice. Science 1992; 258: 1804-1808.
118. Pattarini R, Pittaluga A, Raiteri M. The human immunodeficiency
virus-1 envelope protein gp120 binds through its V3 sequence to
the glycine site of N-methyl-D-aspartate receptors mediating
noradrenaline release in the hippocampus. Neuroscience 1998;
87: 147-157.
98. Wong JK, Ignacio CC, Torriani F, et al. In vivo
compartmentalization of human immunodeficiency virus:
evidence from the examination of pol sequences from autopsy
tissues. J Virol 1997; 71: 2059-2071.
119. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel
Hospital, Boston. Dementia associated with the acquired
immunodeficiency syndrome. N Engl J Med 1995; 332: 934-940.
99. Zhang K, Hawken M, Rana F, et al. Human immunodeficiency
Virus type 1 Clade A and neurotropism: molecular evolution,
30